In the foreseeable future, advancements in molecular biology and metabolomics may facilitate the identification of distinct postbiotic constituents that exert direct effects on allergy-related pathways, including the modulation of IgE-mediated immune responses. This evidence concerns the gene IGHE and allergic disease.